An Overview of Cebior

The Center for Biomedical Research (CEBIOR) has been established almost 19 years ago. It ascertained in 1999 as a biotechnology laboratory and became an authoritative institute in Faculty of Medicine, Diponegoro University (FMDU). CEBIOR used to be located at Gedung Serba Guna Building 2nd floor, Jl. Dr. Soetomo No.14 Semarang. Along with the new University hospital (Diponegoro National Hospital) located at the main campus in Tembalang, in November 2014 Cebior moved to the main laboratory near by the hospital at Laboratorium Sentral Building 2nd floor, Jl. Prof. H. Soedarto, SH, Tembalang, Semarang.

At the start of SUDR (Six Universities Development & Rehabilitation) project ADB-loan in 1993, CEBIOR was not even in mind. Initially, the goal of FMDU was only to develop its undergraduate program especially in Cytogenetics and Immunology. Financial support from SUDR project-ADB-loan has resulted into counterpart formation, collaboration with overseas, native academic consultants, and planning a new multipurpose laboratory. The commencement of SUDR project was a preliminary step for the development of CEBIOR.

Several obstacles have occured during the establishment of CEBIOR for nearly 6 years from 1994-1999. Dr. Soejoto, Sp.KK (K), vice-dean at that time, initiated to unite multidisciplinary experts to arouse the plans of CEBIOR which had been in a long hibernation. CEBIOR was established in 1999 with the initial name “Medical Biotechnology Laboratory”. By the minimum fund and facility, Medical Biotechnology Laboratory was able to survive day by day and year by year.

During nearly 19 years of struggles, Medical Biotechnology Laboratory have been led by three dedicated people. They are Drs. Damin Soemardjo, Prof.Dr.dr.R. Djokomoeljanto, SpPD-KEMD, and the current director, Prof. dr. Sultana MH Faradz, PhD. The name CEBIOR, Center for Biomedical Research, was used for the first time in 2007 replacing the name Medical Biotechnology Laboratory. The name CEBIOR was considered to be more appropriate with science development at this time and also to match better with its brand new visions and missions.

CEBIOR researchs nowadays are focusing on the Mental Retardation and Autism, Disorders of Sex Development, Cancer Genetics, Infertility and Reproductive Genetics, and DNA Polymorphism in infectious diseases such as DHF as well as Leptospirosis. Other studies in immunology are cytokines and molecular studies on infectious disease as well as the effects of some drugs including herbal medicine. Since being appointed as the head of Molecular and Cytogenetics Unit, Prof. dr. Sultana MH Faradz, PhD has led CEBIOR to tremendous development, especially for the facilities and collaborations. Cooperation with RUNMC (Radboud University Nijmegen Medical Centre) Netherlands has made CEBIOR being amazingly better developed than before.

At this time, CEBIOR has 22 staffs from various divisions, 5 technicians, and an administrative staff. Countless research projects have been performed and frequent partnerships have been approved. As the center that actively explores science, CEBIOR keeps on pursuing more developments and achievements in the future; all of this is dedicated to UNDIP to become a Research University in 2020.